Table 3.

Differences in aggregated contraindication scores^a (M/SD) based on demographic and professional variables.

	M (SD)	F	t	p-Value	Effect sizeb
Physicians
Sex
Male (N = 283)	0.32 (0.14)		1.83	0.067	0.15
Female (N = 255)	0.34 (0.13)
Age
<45 years (N = 228)	0.30 (0.12)		−3.57	<0.001	0.29
≥45 years (N = 311)	0.34 (0.15)
Oncology nurses
Sex
Male (N = 68)	0.37 (0.16)		1.18	0.239	0.13
Female (N = 311)	0.39 (0.15)
Age
<45 years (N = 247)	0.40 (0.15)		2.03	0.044	0.19
≥45 years (N = 139)	0.37 (0.16)
Physicians and oncology nurses
Professional background
General practitioners	0.34 (0.13)	11.43	–	<0.001	0.08
Medical oncologists	0.24 (0.09)
Radiation oncologists	0.34 (0.13)
Gastroenterologists	0.30 (0.14)
Urologists	0.36 (0.13)
Gynecologists	0.36 (0.15)
Surgeons	0.31 (0.16)
Oncology nurses	0.39 (0.15)
HCP treating with curative intent (N = 494)	0.36 (0.15)	–	3.42	0.001	0.27
HCP treating with palliative intent (N = 173)c	0.32 (0.14)
HCP who recommend PA on <90% of their visits (N = 535)	0.38 (0.16)	–	5.82	<0.001	0.41
HCP who recommend PA on ≥90% of their visits (N = 388)	0.32 (0.13)

^aThe aggregated contraindication score is a result of the equation [(sum no-answers*0 + sum potentially answers*0.5 + sum yes-answers*1)/number of valid answers] calculated for each participant and then averaged for the different subgroups. This score can adopt values between 0 and 1. Higher values indicate a more cautious perception of medical conditions as contraindications.

^bEffect sizes: partial η² for the ANOVA, d for t-tests.

^cHCP treating with curative intent: >60% curative patients; HCP treating with palliative intent: >60% palliative patients.

M, mean; HCP, health care professionals; PA, physical activity.